-
Hong Kong’s first medical research based on real-world data through big data analytics confirmed the effectiveness of vaccines against Omicron BA.2
Studies also showed COVID-19 vaccines offer the elderly over 90% protection against hospitalisation, severe complication, and mortality.
-
D²4H was featured in RTHK’s programme “I&T New Era II (創科新里程 II)”
D²4H was featured in an episode of RTHK’s programme “I&T New Era II (創科新里程 II)” aired on December 10, 2022.
-
D²4H showcased R&D achievements at Asia Summit on Global Health
Research team of the D²4H participated in the Asia Summit on Global Health (ASGH) jointly organised by the HKSAR Government and the Hong Kong Trade Development Council on November 10 & 11, 2022,
-
Visit by the Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITP)
Professor Joseph Wu, Managing Director, and Mr Cyrus Lam, Chief of Staff of the D²4H met three representatives from the Hong Kong-Shenzhen Innovation and Technology Park Limited, namely Ir Patrick Siu, Chief Executive Officer; Ms Michelle Kam, Director, Operations; and Ms Dora Chin, Associate Director, Business Development of the Company on September 20, 2022 to speak on the latest development and exchange views on collaboration opportunities between the two companies as well as among the innovation and technology sector in Hong Kong.
-
D²4H’s research team introduced the new AI-enabled platform “ausculto”
D²4H’s research team introduced the new AI-enabled platform “ausculto” in the “WAIC 2022 – Hong Kong Branch” held on September 1, 2022.
-
D²4H organised the “AI and Big Data Research for Health Improvement Symposium – Panel Discussion”
Partnering with four organisations, the D²4H organised the “AI and Big Data Research for Health Improvement Symposium – Panel Discussion” on August 31, 2022.
NEWS & EVENTS